FORMES CRISTALLINES D'IBRUTINIB

• 收藏
• 分享

专利权人:

Sun Pharmaceutical Industries Ltd

发明人:

申请号：

EP16836715.9

公开号：

EP3337485A4

申请日:

2016.08.10

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention relates to crystalline forms of ibrutinib, designated as Form S1, Form S2, Form S3, Form S4, and an amorphous form, designated as Form A1, and processes for their preparation, pharmaceutical compositions comprising these forms, and their use for the treatment of Bruton's tyrosine kinase (BTK) mediated diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/